OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Selina Drag, Farokh Dotiwala, Arun K. Upadhyay
Investigative Ophthalmology & Visual Science (2023) Vol. 64, Iss. 7, pp. 39-39
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Mitochondrial diseases: from molecular mechanisms to therapeutic advances
Hu Wen, Hui Deng, Bingyan Li, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4

Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs
Virginie Baylot, Thi Khanh Le, David Taïeb, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 10

Mannose-coupled AAV2: A second-generation AAV vector for increased retinal gene therapy efficiency
Mathieu Mével, Virginie Pichard, Mohammed Bouzelha, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 1, pp. 101187-101187
Open Access | Times Cited: 8

Genetic advancements in breast cancer treatment: a review
Marzieh Shokoohi, Sadaf Sedaghatshoar, Homaira Arian, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Advances in Regenerative Medicine, Cell Therapy, and 3D Bioprinting for Glaucoma and Retinal Diseases
Kevin Y. Wu, Rahma M Osman, Obinna Esomchukwu, et al.
Advances in experimental medicine and biology (2025)
Closed Access | Times Cited: 1

Oxidative Stress and Cataract Formation: Evaluating the Efficacy of Antioxidant Therapies
Merve Kulbay, Kevin Y. Wu, Gurleen K. Nirwal, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1055-1055
Open Access | Times Cited: 7

Piceid Octanoate Protects Retinal Cells against Oxidative Damage by Regulating the Sirtuin 1/Poly-ADP-Ribose Polymerase 1 Axis In Vitro and in rd10 Mice
Seyed Mohamadmehdi Moshtaghion, Estefanía Caballano‐Infantes, Álvaro Plaza Reyes, et al.
Antioxidants (2024) Vol. 13, Iss. 2, pp. 201-201
Open Access | Times Cited: 6

Seeing the Future: A Review of Ocular Therapy
Maiya Whalen, Monica Akula, Shannon M. McNamee, et al.
Bioengineering (2024) Vol. 11, Iss. 2, pp. 179-179
Open Access | Times Cited: 6

Asymmetric Activation of ON and OFF Pathways in the Degenerated Retina
Maya Carleton, Nicholas W. Oesch
eNeuro (2024) Vol. 11, Iss. 5, pp. ENEURO.0110-24.2024
Open Access | Times Cited: 6

Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases
Yiming Zhang, Yesi Shi, Muhammad Munif Khan, et al.
Trends in biotechnology (2024) Vol. 42, Iss. 11, pp. 1439-1452
Closed Access | Times Cited: 6

Exploring gellan gum-based hydrogels for regenerating human embryonic stem cells in age-related macular degeneration therapy: A literature review
Mthabisi Talent George Moyo, Terin Adalı, Pınar Tulay
Regenerative Therapy (2024) Vol. 26, pp. 235-250
Open Access | Times Cited: 6

Gene Therapy for Inherited Retinal Diseases: From Laboratory Bench to Patient Bedside and Beyond
Anand Singh Brar, Deepika C Parameswarappa, Brijesh Takkar, et al.
Ophthalmology and Therapy (2023) Vol. 13, Iss. 1, pp. 21-50
Open Access | Times Cited: 13

The AAV2.7m8 capsid packages a higher degree of heterogeneous vector genomes than AAV2
Mengtian Cui, Qin Su, Mitchell Yip, et al.
Gene Therapy (2024) Vol. 31, Iss. 9-10, pp. 489-498
Closed Access | Times Cited: 5

Cell-cell interaction in the pathogenesis of inherited retinal diseases
Xue Du, Anna G. Butler, Holly Y. Chen
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4

Suprachoroidal gene transfer with nonviral nanoparticles in large animal eyes
Jikui Shen, Raquel Lima e Silva, Mingliang Zhang, et al.
Science Advances (2024) Vol. 10, Iss. 10
Open Access | Times Cited: 4

Unlocking ocular therapy: Harnessing the power of non-coding RNAs
Vahideh Mohammadzadeh, Neda Mostajeran, Mina Shaban, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 98, pp. 105847-105847
Closed Access | Times Cited: 4

Advances in Ophthalmic Therapeutic Delivery: A Comprehensive Overview of Present and Future Directions
Ali Torkashvand, Afshin Izadian, Amir Reza Hajrasouliha
Survey of Ophthalmology (2024) Vol. 69, Iss. 6, pp. 967-983
Closed Access | Times Cited: 4

Non-Viral Delivery Systems to Transport Nucleic Acids for Inherited Retinal Disorders
Md Jobair Jony, Akshada Joshi, Alekha K. Dash, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 87-87
Open Access

From bench to bedside: Developing CRISPR/Cas-based therapy for ocular diseases
Qing Zhao, L. J. Wei, Youxin Chen
Pharmacological Research (2025), pp. 107638-107638
Open Access

Looking to the Future of Viral Vectors in Ocular Gene Therapy: Clinical Review
Chulpan B. Kharisova, Kristina V. Kitaeva, Valeriya V. Solovyeva, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 365-365
Open Access

The role of retinal pigment epithelial senescence and the potential of senotherapeutics in age-related macular degeneration
Yingying Chen, Feipeng Jiang, Yue Zeng, et al.
Survey of Ophthalmology (2025)
Closed Access

Gene Therapy for Cystic Fibrosis: Overcoming Current Limitations and Future Directions
Nadir Ali Wassan, Asfia Qammar, Sarah Bürki, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 3, pp. 133-145
Closed Access

Page 1 - Next Page

Scroll to top